100% agree with this assessment. JN.1 + F456L and R346T should be the target of the next vaccine update, not just the base JN.1. Both mutations are growing substantially on JN.1* and have evolved in prior variants. @WHO @ScottGottliebMD @PeacockFlu @mvankerkhove @EricTopol
100% agree with this assessment. JN.1 + F456L and R346T should be the target of the next vaccine update, not just the base JN.1. Both mutations are growing substantially on JN.1* and have evolved in prior variants. @WHO @ScottGottliebMD @PeacockFlu @mvankerkhove @EricTopol
@JPWeiland @WHO @ScottGottliebMD @PeacockFlu @mvankerkhove @EricTopol Hopefully @yunlong_cao and his group do a study on FLiRT’s and perhaps even how a JN.1 vaccine would respond to them. His work has been highly influential in the decision making process for vaccine updates worldwide.